ANALYSIS OF SOME RISK FACTORS IN STROKE PATIENTS AGED UNDER 45

Hải Linh Nguyễn1,, Văn Tuyến Nguyễn1, Đức Thuần Đỗ2
1 108 Military Central Hospital
2 103 Military Hospital

Main Article Content

Abstract

Purpose: To investigate some risk factors and analyze the correlation in stroke patients under 45 years of age. Methods: A "case-control" study, a cross-sectional description of 130 subjects. Patients were divided into two groups from under 45 years old (research group) and over 45 years old (control group) at Stroke Department- 108 Central Military Hospital and 103 Military Hospital. Results: The most common history is hypertension (42.4%); alcoholism and smoking (18.2% and 25.8%); heart failure, cardiomyopathy, mitral valve stenosis, atrial fibrillation accounted for 12.1%; other diseases (Coagulopathy/ Moyamoya) is 7.5%; Normal medical history is 36.4% - statistically significant difference compared to controls. Adherence to pre-hospital hypertension treatment was associated with a 0.177 times lower risk of stroke [OR=0.177; (0.047-0.663), 0.006] compared with no treatment. Alcoholism and tobacco use were 3,354 and 3,462 times higher, respectively, compared with non-users. Obesity (based on BMI) was higher in the study group than in the control group, p<0.05. Conclusion: The modifiable risk factors account for a high proportion of stroke under 45 years of age, non-compliance with treatment regimen and lifestyle increase the risk of stroke.

Article Details

References

1. H. P. Adams et al., “Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST),” Neurology, vol. 53, no. 1, pp. 126–131, Jul. 1999, doi: 10.1212/WNL.53.1.126.
2. D. Mozaffarian et al., “Heart Disease and Stroke Statistics—2015 Update,” Circulation, vol. 131, no. 4, Jan. 2015, doi: 10.1161/CIR.0000000000000152.
3. M. J. O’Donnell et al., “Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study,” The Lancet, vol. 376, no. 9735, pp. 112–123, Jul. 2010, doi: 10.1016/S0140-6736 (10)60834-3.
4. M. J. O’Donnell et al., “Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study,” Lancet, vol. 388, no. 10046, pp. 761–775, Aug. 2016, doi: 10.1016/S0140-6736(16)30506-2.
5. M. J. Bos, P. J. Koudstaal, A. Hofman, and M. A. Ikram, “Modifiable Etiological Factors and the Burden of Stroke from the Rotterdam Study: A Population-Based Cohort Study,” PLoS Med, vol. 11, no. 4, p. e1001634, 2014, doi: 10.1371/ JOURNAL.PMED.1001634.
6. B. Mallmann, S. C. Fuchs, M. Gus, F. D. Fuchs, and L. B. Moreira, “Population-Attributable Risks for Ischemic Stroke in a Community in South Brazil: A Case-Control Study,” PLoS One, vol. 7, no. 4, p. e35680, Apr. 2012, doi: 10.1371/JOURNAL.PONE.0035680.
7. J. Putaala et al., “Analysis of 1008 Consecutive Patients Aged 15 to 49 With First-Ever Ischemic Stroke,” Stroke, vol. 40, no. 4, pp. 1195–1203, Apr. 2009, doi: 10.1161/STROKEAHA.108.529883.
8. K. Boehme, C. Esenwa, and M. S. V. Elkind, “Stroke Risk Factors, Genetics, and Prevention,” Circ Res, vol. 120, no. 3, p. 472, Feb. 2017, doi: 10.1161/CIRCRESAHA.116.308398.
9. M. Awadh, N. MacDougall, C. Santosh, E. Teasdale, T. Baird, and K. W. Muir, “Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation,” Stroke, vol. 41, no. 9, pp. 1990–1995, Sep. 2010, doi: 10.1161/ STROKEAHA.109.569459.
10. Aigner, U. Grittner, A. Rolfs, B. Norrving, B. Siegerink, and M. A. Busch, “Contribution of Established Stroke Risk Factors to the Burden of Stroke in Young Adults,” Stroke, vol. 48, no. 7, pp. 1744–1751, Jul. 2017, doi: 10.1161/ STROKEAHA.117.016599.